LEVOPRONT

This brand name is authorized in Estonia, Lithuania, Poland, Romania, Singapore, Turkey.

Active ingredients

The drug LEVOPRONT contains one active pharmaceutical ingredient (API):

1
UNII 3O31P6T4G3 - LEVODROPROPIZINE
 

Levodropropizine is a drug provided with a mainly peripheral tracheobronchial antitussive effect together with an antiallergic and antibronchospastic effect.
 
Read more about Levodropropizine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
R05DB27 Levodropropizine R Respiratory system → R05 Cough and cold preparations → R05D Cough suppressants, excl. combinations with expectorants → R05DB Other cough suppressants
Discover more medicines within R05DB27

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EE Ravimiamet 1036921, 1077735
LT Valstybinė vaistų kontrolės tarnyba 1019653, 1019654
PL Rejestru Produktów Leczniczych 100105368, 100307304, 100334838, 100390860, 100451169
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W59205002, W59206001, W66910001, W66910002
SG Health Sciences Authority 10823P
TR İlaç ve Tıbbi Cihaz Kurumu 8699514010920, 8699514010937, 8699514570059, 8699514570066, 8699514573715

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈